A small Massachusetts-based company has developed the first US Food and Drug Administration-cleared and CE-marked medical device system for transporting donor hearts and wants to turn traditional organ transportation on its head.
This February, Paragonix Technologies raised $7m in a preferred Series A round, which allowed it to hire five sales representatives...